Prosecution Insights
Last updated: October 27, 2026

Georgiana C Reglas, USPTO Patent Examiner

Listed by the USPTO as REGLAS, GEORGIANA C

Tech Center 1700 • Art Units: 1651 1653 1654 1656 1657 1799

This examiner grants 39% of resolved cases

Analysis

REGLAS, GEORGIANA C handles cases in tech center 1700 and art unit 1651. The profile shows 79 resolved cases, a 39.2% allowance rate, and a median of 1333 days to allowance. The interview lift is 33.4%, indicating that interviews are associated with a meaningful improvement in allowance outcomes in the available data.

The leading companies are Fujifilm Corporation, Kashiv Biosciences LLC, and California Institute of Technology. The listed firms are LEYDIG VOIT & MAYER, LTD, Meunier Carlin & Curfman LLC, and SEED INTELLECTUAL PROPERTY LAW GROUP LLP. The limited case volume makes application-specific review important, but the interview figure supports deliberate interview preparation. The 1333-day median also indicates that applicants should plan for extended prosecution and coordinate continuation decisions with portfolio needs.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

39.2%
Allow Rate
-25.8% vs TC avg
135
Total Applications
+33.4%
Interview Lift
1333
Avg Prosecution Days
Based on 79 resolved cases, 2023–2026

Rejection Statute Breakdown

7.1%
§101 Eligibility
12.3%
§102 Novelty
39.1%
§103 Obviousness
28.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18347733 METHOD FOR SELECTING CELLS, APPARATUS, AND APPARATUS SYSTEM Non-Final OA FUJIFILM Corporation
19432924 AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN Final Rejection Kashiv BioSciences, LLC
18585375 TRANSCRIPTION TERMINATOR BIOPARTS BASED ON 3'-UNTRANSLATED REGION (UTR) AND A METABOLIC ENGINEERING METHOD THEREOF Non-Final OA KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
17558186 FUNCTIONAL COMPOSITE MEMBRANES FOR CHROMATOGRAPHY AND CATALYSIS Final Rejection California Institute of Technology
17438025 STORAGE LIQUID FOR MAMMALIAN CELLS Non-Final OA OTSUKA PHARMACEUTICAL FACTORY, INC.
17058891 TARGETING ANABOLIC DRUGS FOR ACCELERATED FRACTURE REPAIR Non-Final OA Purdue Research Foundation
19054625 THERARONSTIC APPROACH FOR INFLAMMATORY BOWEL DISEASE-ASSOCIATED SPONDYLOARTHRITIS Non-Final OA Cornell University
17442776 PROBIOTIC BACTERIA CAPABLE OF ADAPTIVE RESPONSE TO POMEGRANATE EXTRACT AND METHODS OF PRODUCTION AND USE THEREOF Non-Final OA North Carolina State University
18977400 METHODS OF USING THERMOSTABLE SERINE PROTEASES Non-Final OA INTERNATIONAL N&H DENMARK APS
18260861 PROTEIN HAVING L-PROLINE EFFLUX FUNCTION, AND USE THEREOF Non-Final OA TIANJIN INSTITUTE OF INDUSTRIAL BIOTECHNOLOGY, CHINESE ACADEMY OF SCIENCES

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Georgiana C Reglas's allowance rate?

39.2% of resolved applications examined by Georgiana C Reglas were allowed (79 resolved cases), compared with 31.6% across Art Unit 1651 over the last five years.

Does an interview help with examiner Georgiana C Reglas?

This examiner's interview lift is +33.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Georgiana C Reglas take to allow a patent?

Applications allowed by Georgiana C Reglas took 1,333 days on average from filing to allowance.

Which art unit does examiner Georgiana C Reglas work in?

Georgiana C Reglas examines applications in Art Unit 1651 in Tech Center 1700 (Chemistry & Materials).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month